Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.

Poesen K, De Schaepdryver M, Stubendorff B, Gille B, Muckova P, Wendler S, Prell T, Ringer TM, Rhode H, Stevens O, Claeys KG, Couwelier G, D'Hondt A, Lamaire N, Tilkin P, Van Reijen D, Gourmaud S, Fedtke N, Heiling B, Rumpel M, Rödiger A, Gunkel A, Witte OW, Paquet C, Vandenberghe R, Grosskreutz J, Van Damme P.

Neurology. 2017 May 12. pii: 10.1212/WNL.0000000000004029. doi: 10.1212/WNL.0000000000004029. [Epub ahead of print]

PMID:
28500227
2.

Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.

Steinacker P, Huss A, Mayer B, Grehl T, Grosskreutz J, Borck G, Kuhle J, Lulé D, Meyer T, Oeckl P, Petri S, Weishaupt J, Ludolph AC, Otto M.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):112-119. doi: 10.1080/21678421.2016.1241279. Epub 2016 Nov 5.

PMID:
27819158
3.

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis.

Menke RA, Agosta F, Grosskreutz J, Filippi M, Turner MR.

Neurotherapeutics. 2017 Jan;14(1):11-23. doi: 10.1007/s13311-016-0484-9. Review.

4.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, Võsa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT, Tazelaar GH, Koppers M, Blokhuis AM, Sproviero W, Jones AR, Kenna KP, van Eijk KR, Harschnitz O, Schellevis RD, Brands WJ, Medic J, Menelaou A, Vajda A, Ticozzi N, Lin K, Rogelj B, Vrabec K, Ravnik-Glavač M, Koritnik B, Zidar J, Leonardis L, Grošelj LD, Millecamps S, Salachas F, Meininger V, de Carvalho M, Pinto S, Mora JS, Rojas-García R, Polak M, Chandran S, Colville S, Swingler R, Morrison KE, Shaw PJ, Hardy J, Orrell RW, Pittman A, Sidle K, Fratta P, Malaspina A, Topp S, Petri S, Abdulla S, Drepper C, Sendtner M, Meyer T, Ophoff RA, Staats KA, Wiedau-Pazos M, Lomen-Hoerth C, Van Deerlin VM, Trojanowski JQ, Elman L, McCluskey L, Basak AN, Tunca C, Hamzeiy H, Parman Y, Meitinger T, Lichtner P, Radivojkov-Blagojevic M, Andres CR, Maurel C, Bensimon G, Landwehrmeyer B, Brice A, Payan CA, Saker-Delye S, Dürr A, Wood NW, Tittmann L, Lieb W, Franke A, Rietschel M, Cichon S, Nöthen MM, Amouyel P, Tzourio C, Dartigues JF, Uitterlinden AG, Rivadeneira F, Estrada K, Hofman A, Curtis C, Blauw HM, van der Kooi AJ, de Visser M, Goris A, Weber M, Shaw CE, Smith BN, Pansarasa O, Cereda C, Del Bo R, Comi GP, D'Alfonso S, Bertolin C, Sorarù G, Mazzini L, Pensato V, Gellera C, Tiloca C, Ratti A, Calvo A, Moglia C, Brunetti M, Arcuti S, Capozzo R, Zecca C, Lunetta C, Penco S, Riva N, Padovani A, Filosto M, Muller B, Stuit RJ; PARALS Registry.; SLALOM Group.; SLAP Registry.; FALS Sequencing Consortium.; SLAGEN Consortium.; NNIPPS Study Group., Blair I, Zhang K, McCann EP, Fifita JA, Nicholson GA, Rowe DB, Pamphlett R, Kiernan MC, Grosskreutz J, Witte OW, Ringer T, Prell T, Stubendorff B, Kurth I, Hübner CA, Leigh PN, Casale F, Chio A, Beghi E, Pupillo E, Tortelli R, Logroscino G, Powell J, Ludolph AC, Weishaupt JH, Robberecht W, Van Damme P, Franke L, Pers TH, Brown RH, Glass JD, Landers JE, Hardiman O, Andersen PM, Corcia P, Vourc'h P, Silani V, Wray NR, Visscher PM, de Bakker PI, van Es MA, Pasterkamp RJ, Lewis CM, Breen G, Al-Chalabi A, van den Berg LH, Veldink JH.

Nat Genet. 2016 Sep;48(9):1043-8. doi: 10.1038/ng.3622. Epub 2016 Jul 25.

PMID:
27455348
5.

Down-regulation of purinergic P2X7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis.

Liu J, Prell T, Stubendorff B, Keiner S, Ringer T, Gunkel A, Tadic V, Goldhammer N, Malci A, Witte OW, Grosskreutz J.

Neurosci Lett. 2016 Sep 6;630:77-83. doi: 10.1016/j.neulet.2016.07.039. Epub 2016 Jul 21.

PMID:
27453058
6.

The intricacy of biomarker complexity-the identification of a genuine proteomic biomarker is more complicated than believed.

Büchler R, Wendler S, Muckova P, Großkreutz J, Rhode H.

Proteomics Clin Appl. 2016 Nov;10(11):1073-1076. doi: 10.1002/prca.201600067. Epub 2016 Jul 29.

PMID:
27377180
7.

Assessment of the upper motor neuron in amyotrophic lateral sclerosis.

Huynh W, Simon NG, Grosskreutz J, Turner MR, Vucic S, Kiernan MC.

Clin Neurophysiol. 2016 Jul;127(7):2643-60. doi: 10.1016/j.clinph.2016.04.025. Epub 2016 May 5. Review.

8.

Critical illness polyneuropathy in ICU patients is related to reduced motor nerve excitability caused by reduced sodium permeability.

Koch S, Bierbrauer J, Haas K, Wolter S, Grosskreutz J, Luft FC, Spies CD, Fielitz J, Weber-Carstens S.

Intensive Care Med Exp. 2016 Dec;4(1):10. doi: 10.1186/s40635-016-0083-4. Epub 2016 May 20.

9.

Quality Control of Motor Unit Number Index (MUNIX) Measurements in 6 Muscles in a Single-Subject "Round-Robin" Setup.

Neuwirth C, Burkhardt C, Alix J, Castro J, de Carvalho M, Gawel M, Goedee S, Grosskreutz J, Lenglet T, Moglia C, Omer T, Schrooten M, Weber M.

PLoS One. 2016 May 2;11(5):e0153948. doi: 10.1371/journal.pone.0153948. eCollection 2016.

10.

Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?

Prell T, Ringer TM, Wullenkord K, Garrison P, Gunkel A, Stubendorff B, Witte OW, Grosskreutz J.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1022-6. doi: 10.1136/jnnp-2015-312185. Epub 2016 Mar 24.

11.

Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.

Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterlé S, Dengler R, Meyer T, Zierz S, Kassubek J, Fischer W, Dreyhaupt J, Grehl T, Hermann A, Grosskreutz J, Witting A, Van Den Bosch L, Spreux-Varoquaux O; GERP ALS Study Group., Ludolph AC, Dupuis L.

Brain. 2016 Apr;139(Pt 4):1106-22. doi: 10.1093/brain/aww004. Epub 2016 Mar 16.

PMID:
26984187
12.

A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis.

Müller HP, Turner MR, Grosskreutz J, Abrahams S, Bede P, Govind V, Prudlo J, Ludolph AC, Filippi M, Kassubek J; Neuroimaging Society in ALS (NiSALS) DTI Study Group..

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):570-9. doi: 10.1136/jnnp-2015-311952. Epub 2016 Jan 8.

PMID:
26746186
13.

Novel computer vision algorithm for the reliable analysis of organelle morphology in whole cell 3D images--A pilot study for the quantitative evaluation of mitochondrial fragmentation in amyotrophic lateral sclerosis.

Lautenschläger J, Lautenschläger C, Tadic V, Süße H, Ortmann W, Denzler J, Stallmach A, Witte OW, Grosskreutz J.

Mitochondrion. 2015 Nov;25:49-59. doi: 10.1016/j.mito.2015.10.003. Epub 2015 Oct 9.

PMID:
26440825
14.

Mind the gap: the mismatch between clinical and imaging metrics in ALS.

Verstraete E, Turner MR, Grosskreutz J, Filippi M, Benatar M; attendees of the 4th NiSALS meeting..

Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):524-9. doi: 10.3109/21678421.2015.1051989. Epub 2015 Sep 24.

PMID:
26402254
15.

[Provision of assistive devices in amyotrophic lateral sclerosis. Analysis of 3 years case management in an internet-based supply network].

Funke A, Grehl T, Großkreutz J, Münch C, Walter B, Kettemann D, Karnapp C, Gajewski N, Meyer R, Maier A, Gruhn KM, Prell T, Kollewe K, Abdulla S, Kobeleva X, Körner S, Petri S, Meyer T.

Nervenarzt. 2015 Aug;86(8):1007-17. doi: 10.1007/s00115-015-4398-2. German.

PMID:
26220007
16.

Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis.

Filippi M, Agosta F, Grosskreutz J, Benatar M, Kassubek J, Verstraete E, Turner MR; Neuroimaging Society in ALS (NiSALS)..

Lancet Neurol. 2015 Aug;14(8):786-8. doi: 10.1016/S1474-4422(15)00134-9. No abstract available.

PMID:
26194923
17.

Susceptibility-weighted imaging provides insight into white matter damage in amyotrophic lateral sclerosis.

Prell T, Hartung V, Tietz F, Penzlin S, Ilse B, Schweser F, Deistung A, Bokemeyer M, Reichenbach JR, Witte OW, Grosskreutz J.

PLoS One. 2015 Jun 25;10(6):e0131114. doi: 10.1371/journal.pone.0131114. eCollection 2015.

18.

Obsessive-compulsive disorder is a heterogeneous disorder: evidence from diffusion tensor imaging and magnetization transfer imaging.

Glahn A, Prell T, Grosskreutz J, Peschel T, Müller-Vahl KR.

BMC Psychiatry. 2015 Jun 25;15:135. doi: 10.1186/s12888-015-0535-5.

19.

Muscle ultrasonography as an additional diagnostic tool for the diagnosis of amyotrophic lateral sclerosis.

Grimm A, Prell T, Décard BF, Schumacher U, Witte OW, Axer H, Grosskreutz J.

Clin Neurophysiol. 2015 Apr;126(4):820-7. doi: 10.1016/j.clinph.2014.06.052. Epub 2014 Aug 21.

PMID:
25204706
20.

Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis.

Hartung V, Prell T, Gaser C, Turner MR, Tietz F, Ilse B, Bokemeyer M, Witte OW, Grosskreutz J.

PLoS One. 2014 Aug 18;9(8):e104894. doi: 10.1371/journal.pone.0104894. eCollection 2014.

Supplemental Content

Loading ...
Support Center